| Filed On | Filing |
|---|---|
| 14 Nov 2025 | SCHEDULE 13G/A |
| 08 Sep 2025 | 15-12G |
| 04 Sep 2025 | EFFECT |
| 03 Sep 2025 | SCHEDULE 13D/A |
| 29 Aug 2025 |
Form 4: Call Matthew, Chief Operating Officer
Disposed of 161,898 shares (Tender Offer) · Disposed of 416,773 Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Aug 2025 |
Form 4: Detheux Michel, Director
Disposed of 247,930 shares (Tender Offer) · Disposed of 858,708 Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Aug 2025 |
Form 4: Lee David K, Director
Disposed of 44,766 Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Aug 2025 |
Form 4: Feltquate David, Chief Medical Officer
Disposed of 47,000 shares (Tender Offer) |
| 29 Aug 2025 |
Form 4: Gall Matthew, Chief Financial Officer
Disposed of 89,429 shares (Tender Offer) · Disposed of 447,646 Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Aug 2025 |
Form 4: McGrath Yvonne, Chief Scientific Officer
Disposed of 46,300 shares (Tender Offer) · Disposed of 176,123 Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Aug 2025 |
Form 4: Rhoads Ann D, Director
Disposed of 27,178 Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Aug 2025 |
Form 4: Hallal David, Director
Disposed of 171,300 Stock Option (Right to Buy) (Disposition to Issuer) |
| 29 Aug 2025 | S-8 POS |
| 29 Aug 2025 | S-8 POS |
| 29 Aug 2025 | S-8 POS |
| 29 Aug 2025 | S-8 POS |
| 29 Aug 2025 | S-8 POS |
| 29 Aug 2025 | S-8 POS |
| 29 Aug 2025 | POS AM |
| 29 Aug 2025 | 25-NSE |
Loading...
